Clinical Trials Browser

Unknown × Prostate Cancer Metastatic × Docetaxel × Clear all

NCT04603833 2021-02-21

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Phase 2 Unknown

Prostate Cancer Metastatic